Feroscan
Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action.
Launch date
Market cap
-
Enterprise valuation
CAD2—3m (Dealroom.co estimates Jul 2018.)
Company register number 807657747
Paris Île-de-France (HQ)